HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Desloges, N. Articles by Wolff, M. H. Search for Related Content PubMed PubMed Citation Articles by Desloges, N. Articles by Wolff, M. H. Agricola Articles by Desloges, N. Articles by Wolff, M. H.

Role of the protein kinase PKR in the inhibition of varicella-zoster virus replication by beta interferon and gamma interferon

University of Witten/Herdecke, Institute of Microbiology and Virology, Stockumer Str. 10, D-58448 Witten, Germany

Correspondence
Manfred H. Wolff
mhwolff{at}uni-wh.de

Varicella-zoster virus (VZV) is sensitive to type I and type II interferons (IFNs), which mediate antiviral effects. In this study, it was demonstrated that IFN- and IFN- inhibited the replication of VZV in vitro. Although IFN- was more effective than IFN-, the level of inhibition of VZV replication achieved by the combination of both IFNs was more than additive and it was concluded that these two cytokines acted synergistically. Expression of the IFN-induced, double-stranded RNA-activated protein kinase PKR and its phosphorylation level were not modulated strongly during ongoing replication of VZV. However, in the presence of IFN-, but not IFN-, PKR expression and its phosphorylation were increased, explaining in part the inhibition of virus replication by IFNs. The expression of herpes simplex virus Us11, a viral protein with several functions, including prevention of PKR activation, strongly increased the level of VZV replication.

This article has been cited by other articles:

				A. P. N. Ambagala and J. I. Cohen Varicella-Zoster Virus IE63, a Major Viral Latency Protein, Is Required To Inhibit the Alpha Interferon-Induced Antiviral Response J. Virol., August 1, 2007; 81(15): 7844 - 7851. [Abstract] [Full Text] [PDF]

				M. P. Moraes, T. de los Santos, M. Koster, T. Turecek, H. Wang, V. G. Andreyev, and M. J. Grubman Enhanced Antiviral Activity against Foot-and-Mouth Disease Virus by a Combination of Type I and II Porcine Interferons J. Virol., July 1, 2007; 81(13): 7124 - 7135. [Abstract] [Full Text] [PDF]

				M. Rahaus, N. Desloges, and M. H. Wolff Varicella-zoster virus influences the activities of components and targets of the ERK signalling pathway. J. Gen. Virol., April 1, 2006; 87(Pt 4): 749 - 758. [Abstract] [Full Text] [PDF]

				S. Brand, F. Beigel, T. Olszak, K. Zitzmann, S. T. Eichhorst, J.-M. Otte, J. Diebold, H. Diepolder, B. Adler, C. J. Auernhammer, et al. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression Am J Physiol Gastrointest Liver Physiol, November 1, 2005; 289(5): G960 - G968. [Abstract] [Full Text] [PDF]

				A. T. Pierce, J. DeSalvo, T. P. Foster, A. Kosinski, S. K. Weller, and W. P. Halford Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells J. Gen. Virol., September 1, 2005; 86(9): 2421 - 2432. [Abstract] [Full Text] [PDF]